Literature DB >> 25854140

Issues in the Diagnosis and Treatment of Primary Aldosteronism.

Jacopo Burrello1, Silvia Monticone2, Fabrizio Buffolo2, Martina Tetti2, Giuseppe Giraudo3, Domenica Schiavone2, Franco Veglio2, Paolo Mulatero4.   

Abstract

Primary aldosteronism (PA) is associated with a high rate of cardio- and cerebrovascular complications and metabolic alterations. PA is also recognized as the most frequent, although often unrecognized, secondary form of hypertension. Guidelines have been released to assist clinicians in the diagnostic work-up and subtype differentiation of PA. In this review we discuss and compare the available guidelines in the context of our professional experience and evaluate diagnostic and therapeutic aspects that are still a matter of debate.

Entities:  

Keywords:  Adrenal vein sampling; Aldosterone-producing adenoma; Primary aldosteronism; Secondary hypertension

Mesh：

Substances：

Year:  2015        PMID： 25854140     DOI： 10.1007/s40292-015-0084-5

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN： 1120-9879


  98 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stephane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  Blood Press       Date:  2013-12-20       Impact factor: 2.835

3.  Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study.

Authors:  Yoshihiro Miyake; Keiko Tanaka; Tetsuo Nishikawa; Mitsuhide Naruse; Ryoichi Takayanagi; Hironobu Sasano; Yoshiyu Takeda; Hirotaka Shibata; Masakatsu Sone; Fumitoshi Satoh; Masanobu Yamada; Hajime Ueshiba; Takuyuki Katabami; Yasumasa Iwasaki; Hirotoshi Tanaka; Yusuke Tanahashi; Shigeru Suzuki; Tomonobu Hasegawa; Noriyuki Katsumata; Toshihiro Tajima; Toshihiko Yanase
Journal:  Endocr J       Date:  2013-09-28       Impact factor: 2.349

4.  The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Marlena Barisa; Anna Belfiore; Giovambattista Desideri; Claudio Ferri; Claudio Letizia; Mauro Maccario; Alberto Morganti; Gaetana Palumbo; Anna Patalano; Elisabetta Roman; Teresa M Seccia; Achille C Pessina; Franco Mantero
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

5.  Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.

Authors:  Ashraf H Ahmed; Richard D Gordon; Gregory Ward; Martin Wolley; Cynthia Kogovsek; Michael Stowasser
Journal:  Clin Endocrinol (Oxf)       Date:  2015-02-03       Impact factor: 3.478

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  Adrenal adenomas: relationship between histologic lipid-rich cells and CT attenuation number.

Authors:  Takayuki Yamada; Tadashi Ishibashi; Haruo Saito; Toshio Matsuhashi; Kazuhiro Majima; Masashi Tsuda; Shoki Takahashi; Takuya Moriya
Journal:  Eur J Radiol       Date:  2003-11       Impact factor: 3.528

Review 8.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

9.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

10.  Efficacy and tolerance of spironolactone in essential hypertension.

Authors:  X Jeunemaitre; G Chatellier; C Kreft-Jais; A Charru; C DeVries; P F Plouin; P Corvol; J Menard
Journal:  Am J Cardiol       Date:  1987-10-01       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.